Skip to content

A translational nursing intervention study on precision symptom management of radiotherapy-related toxicity in esophageal cancer based on multi-omics biomarkers

A translational nursing intervention study on precision symptom management of radiotherapy-related toxicity in esophageal cancer based on multi-omics biomarkers

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120863
Enrollment
Unknown
Registered
2026-03-20
Start date
2026-03-20
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophagus cancer

Interventions

1:Nutrition plan: Oral retinol (vitamin A soft capsules, 5000 units per day) and nicotinamide precursor supplement [nicotinamide mononucleotide (NMN) (300 mg per day)].
2:CBT-I program: A 5-week structured insomnia cognitive behavioral therapy, including sleep hygiene education, stimulus control, sleep restriction, cognitive restructuring and relaxation training.
3:Combined program: The nutrition plan is implemented in conjunction with the CBT-I program.
4:Control group: Received routine care and health education for tumor radiotherapy.

Sponsors

The Second Affiliated Hospital of Shandong First Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.According to the diagnostic criteria of the World Health Organization (WHO),esophageal squamous cell carcinoma was confirmed by tissue biopsy; the clinical stage was determined in accordance with the 8th edition of the American Joint Committee on Cancer staging manual. 2.Age >= 18 years old. 3.Planned to receive radical radiotherapy. 4.No cognitive impairment, and able to independently complete the questionnaire filling.

Exclusion criteria

Exclusion criteria: 1.Having received previous chest radiotherapy. 2.Having communication or comprehension difficulties. 3.Currently participating in other clinical intervention studies. 4.Long-term use of VA/VB3/NAD^+ supplements. 5.Having severe liver or kidney dysfunction or sleep apnea syndrome.

Design outcomes

Primary

MeasureTime frame
Pittsburgh sleep quality index;PROMIS Sleep Disturbance 8a;PROMIS Sleep Related Impairment;

Secondary

MeasureTime frame
Cancer Fatigue Scale;Quality of Life Questionnaire Core 30;Patient-Generated Subjective Global Assessment;Upper limb muscle strength;Lower limb muscle strength and endurance;Balance and mobility skills;

Countries

China

Contacts

Public ContactZhao Xia Yang

The Second Affiliated Hospital of Shandong First Medical University, Tai'an City, Shandong Province

18505386867@163.com+86 185 0538 6867

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026